Supernus, Inc.
- Last sale
- Nov 2, 2026 · +2.43%
- Market cap
- $4.28B
- 118.04M shares
- Filings
- 572
Q3 2026+4.3% FY25 yoy
Q3 2026+2,900.0% FY25 yoy
Q3 2026+589.5% FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026+3,180.0% FY25 yoy
Q3 2026−38.9% FY25 yoy
- $4.28B
- 9.5×
- 3.1×
- —
- 0.72%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,239,000,000 | reported | |
| FY 2024 | 2024-12-31 | $1,188,000,000 | reported | |
| FY 2023 | 2023-12-31 | $1,093,000,000 | reported | |
| FY 2022 | 2022-12-31 | $901,000,000 | reported | |
| FY 2021 | 2021-12-31 | $791,000,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $11.00M | $11.00M | — | 125.07M sh | +0.3% | — |
| FY2024 | — | $173.00M | $173.00M | — | 124.66M sh | −8.7% | 2471.4% |
| FY2023 | — | $33.00M | $33.00M | — | 136.53M sh | — | — |
| FY2022 | — | $90.00M | $90.00M | — | — | — | — |
| FY2021 | — | $101.00M | $101.00M | — | — | — | 28.9% |
Segments
Geography
LineFY2025ShareChange
US$113.00M66%+52.7%
Rest of World$57.00M34%−12.3%
Total$170.00M
Pharmaceutical preparations
Supernus, Inc. is the 31st largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PAHCPhibro Animal Health Corp$1.5B17.1%6.6%$1.4BALKSAlkermes plc.$1.5B5.2%16.4%$7.9B
INDVSupernus, Inc. (this company)$1.2B4.3%16.9%$3.4B
NSRXNasus Pharma Ltd$1.2B—0.5%$26.6MPBHPrestige Consumer Healthcare Inc.$1.1B4.3%17.5%$2.1BACADAcadia Pharmaceuticals Inc$1.1B11.9%36.5%$3.7BLEGNLegend Biotech Corp$1.0B64.0%28.8%$3.4BMDGLMadrigal Pharmaceuticals, Inc.$958.4M432.1%30.1%$9.9BIONSIonis Pharmaceuticals Inc$943.7M33.8%40.4%$4.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Supernus, Inc. · CIK 1625297 · Engraved from SEC EDGAR